HPI/AMF inhibition halts the development of the aggressive phenotype of breast cancer stem cells
Keywords: BCSC; breast cancer stem cell-like cells; CSC; cancer stem cells; HPI/AMF; hexose phosphate isomerase/autocrine motility factor; E4P; erythrose 4 phosphate; EMT; epithelial mesenchymal transition; Breast cancer; Stem cells; Hexose-phosphate isomerase; Met